Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Reviva To Present RECOVER Phase 3 Clinical Trial Data For Brilaroxazine In Schizophrenia At SIRS 2024 Annual Meeting Apr. 4

Author: Benzinga Newsdesk | March 28, 2024 08:07am

Posted In: RVPH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist